Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

Federica Tomao, Anselmo Papa, Luigi Rossi, Davide Caruso, Federica Zoratto, Pierluigi Benedetti Panici, Silverio Tomao
  • Expert Opinion on Investigational Drugs, October 2013, Informa Healthcare
  • DOI: 10.1517/13543784.2013.839657

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.2013.839657

The following have contributed to this page: Dr Federica Tomao